Candesartan Cilexetil Tablet
Product Images NDC 46708-343

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Candesartan Cilexetil (NDC 46708-343). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30' Bottle Pack (Candesartan 16)

Label for Candesartan Cilexetil Tablets, USP 16 mg from Alembic Pharmaceuticals Limited. The label indicates the product contains 30 tablets, includes storage instructions (store at 25°C with allowed excursions), and notes the tablet is uncoated. The NDC number 46708-343-30 and a barcode are visible, alongside manufacturer details in Gujarat, India.*

FDA Label Image

30' Bottle Pack (Candesartan 4)

Label for Candesartan Cilexetil Tablets USP 4 mg by Alembic Pharmaceuticals Limited. The label includes dosage form as tablets, prescription only (Rx only), and package count of 30 tablets. Storage instructions specify 25°C with permitted excursions. Manufacturer details and barcode are also visible.*

FDA Label Image

30' Bottle Pack (Candesartan 8)

Label for Candesartan Cilexetil Tablets USP 8 mg, oral tablets supplied in a container of 30 tablets. The label includes dosage form, strength, manufacturer Alembic Pharmaceuticals Limited, storage instructions at 25°C with allowable excursions, and a barcode. It indicates Rx only and features the Alembic logo.*

FDA Label Image

Figure (Candesartan Fig)

A forest plot illustrating hazard ratios with 95% confidence intervals comparing Candesartan cilexetil versus placebo. The plot categorizes patients by age, sex, race, NYHA class, left ventricular ejection fraction, and medical history including diabetes, hypertension, prior myocardial infarction, and medication use. Each category displays patient counts and a horizontal line showing the hazard ratio, indicating the relative effect of Candesartan cilexetil compared to placebo.*

FDA Label Image

Structure (Candesartan Str)

Chemical structure diagram of the active ingredient Candesartan Cilexetil showing its molecular components and indicating the site of ester hydrolysis.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.